Correlation Engine 2.0
Clear Search sequence regions


  • articular cartilage (2)
  • b cells (1)
  • carrageenan (6)
  • cartilage (3)
  • cells (2)
  • cellular homeostasis (1)
  • edema (5)
  • factor (2)
  • glutaredoxins (2)
  • GRX- 1 (15)
  • homeostasis (1)
  • human (6)
  • IL 1β (3)
  • interleukin (1)
  • interleukin 1beta (2)
  • male (1)
  • MAPK (5)
  • membranes (1)
  • metalloproteinases (3)
  • mice (2)
  • MMP 13 (3)
  • NF κB (5)
  • nitric oxide (5)
  • PEP 1 (14)
  • peptides (2)
  • redox (1)
  • signal (1)
  • tissues (2)
  • vitro (1)
  • western blot (3)
  • Sizes of these terms reflect their relevance to your search.

    The protein transduction domain (PTD) enables therapeutic proteins to directly penetrate the membranes of cells and tissues, and has been increasingly utilized. Glutaredoxin-1 (GRX-1) is an endogenous antioxidant enzyme involved in the cellular redox homeostasis system. In this study, we investigated whether PEP-1-GRX-1, a fusion protein of GRX-1 and PEP-1 peptide, a PTD, could suppress catabolic responses in primary human articular chondrocytes and a mouse carrageenan-induced paw edema model. Human articular chondrocytes were isolated enzymatically from articular cartilage and cultured in a monolayer. The transduction efficiency of PEP-1-GRX-1 into articular chondrocytes was measured by western blot and immunohistochemistry. The effects of PEP-1-GRX-1 on matrix metalloproteinases (MMPs) and catabolic factor expression in interleukin (IL)-1β- and lipopolysaccharide (LPS)-treated chondrocytes were analyzed by real-time quantitative reverse transcription-polymerase chain reaction and western blot. The effect of PEP-1-GRX1 on the mitogen-activated protein kinase (MAPK) and nuclear factor kappa-light chain-enhancer of activated B cells (NF-κB) signaling pathway were also analyzed by western blot. Finally, the inhibitory effect of PEP-1-GRX-1 on MMP-13 production was measured in vivo in a mouse carrageenan-induced paw edema model. PEP-1-GRX-1 significantly penetrated into human chondrocytes and mouse cartilage, whereas GRX-1 did not. PEP-1-GRX-1 significantly suppressed MMP-13 expression and nitric oxide (NO) production in LPS-stimulated chondrocytes, and NO production in IL-1β-stimulated chondrocytes, compared with GRX-1. In addition, PEP-1-GRX-1 decreased IL-1β- and LPS-induced activation of MAPK and NF-κB. In the mouse model of carrageenan-induced paw edema, PEP-1-GRX-1 significantly suppressed carrageenan-induced MMP-13 production as well as paw edema. These results demonstrate that PEP-1-GRX-1 can be transduced efficiently in vitro and in vivo into human chondrocytes and mouse cartilage tissue and downregulate catabolic responses in chondrocytes by inhibiting the MAPK and NF-κB pathway. PEP-1-GRX-1 thus has the potential to reduce catabolic responses in chondrocytes and cartilage. © 2017 The Author(s). Published by S. Karger AG, Basel.

    Citation

    Hyun Sook Hwang, In Young Park, Hyun Ah Kim, Soo Young Choi. PEP-1-GRX-1 Modulates Matrix Metalloproteinase-13 and Nitric Oxide Expression of Human Articular Chondrocytes. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 2017;41(1):252-264

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28214840

    View Full Text